{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:51:17Z","timestamp":1747356677749},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,5,12]],"date-time":"2009-05-12T00:00:00Z","timestamp":1242086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s00431-009-0997-x","type":"journal-article","created":{"date-parts":[[2009,5,11]],"date-time":"2009-05-11T19:08:43Z","timestamp":1242068923000},"page":"241-243","source":"Crossref","is-referenced-by-count":7,"title":["Titration of betaine therapy to optimize therapy in an infant with 5,10-methylenetetrahydrofolate reductase deficiency"],"prefix":"10.1007","volume":"169","author":[{"given":"Sema Kalkan","family":"Ucar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zge Altun","family":"Koro\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6mer","family":"Berk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Yalaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilg\u00fcn","family":"K\u00fclt\u00fcrsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk J.","family":"Blom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmut","family":"Coker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,12]]},"reference":[{"key":"997_CR1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1023\/A:1005509400481","volume":"22","author":"NG Abeling","year":"1999","unstructured":"Abeling NG, van Gennip AH, Blom H et al (1999) Rapid diagnosis and methionine administration: basis for a favourable outcome in a patient with methylene tetrahydrofolate reductase deficiency. J Inherit Metab Dis 22:240\u2013242","journal-title":"J Inherit Metab Dis"},{"key":"997_CR2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0387-7604(02)00062-1","volume":"24","author":"AA Al Tawari","year":"2002","unstructured":"Al Tawari AA, Ramadan DG, Neubauer D et al (2002) An early onset form of methylenetetrahydrofolate reductase deficiency: a report of a family from Kuwait. Brain Dev 24:304\u2013309","journal-title":"Brain Dev"},{"key":"997_CR3","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/adc.64.7.1061","volume":"64","author":"E Holme","year":"1989","unstructured":"Holme E, Kjellman B, Ronge E (1989) Betaine for treatment of homocystinuria caused by methylenetetrahydrofolate reductase deficiency. Arch Dis Child 64:1061\u20131064","journal-title":"Arch Dis Child"},{"key":"997_CR4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ymgme.2006.02.004","volume":"88","author":"A Lawson-Yuen","year":"2006","unstructured":"Lawson-Yuen A, Levy HL (2006) The use of betaine in the treatment of elevated homocysteine. Mol Genet Metab 88:201\u2013207","journal-title":"Mol Genet Metab"},{"issue":"2","key":"997_CR5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1365-2125.2002.01620.x","volume":"54","author":"A Matthews","year":"2002","unstructured":"Matthews A, Johnson TN, Rostami-Hodjegan A et al (2002) An indirect response model of homocysteine suppression by betaine: optimising the dosage regimen of betaine in homocystinuria. Br J Clin Pharmacol 54(2):140\u2013146","journal-title":"Br J Clin Pharmacol"},{"key":"997_CR6","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0006-291X(72)80227-4","volume":"46","author":"SH Mudd","year":"1972","unstructured":"Mudd SH, Uhlendorf BW, Freeman JM et al (1972) Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity. Biochem Biophys Res Commun 46:905\u2013912","journal-title":"Biochem Biophys Res Commun"},{"key":"997_CR7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1023\/A:1005331902497","volume":"21","author":"N Sakura","year":"1998","unstructured":"Sakura N, Ono H, Nomura S et al (1998) Betaine dose and treatment intervals in therapy for homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. J Inherit Metab Dis 21:84\u201385","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"997_CR8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.01717.x","volume":"55","author":"BC Schwahn","year":"2003","unstructured":"Schwahn BC, Hafner D, Hohlfeld T et al (2003) Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria. Br J Clin Pharmacol 55(1):6\u201313","journal-title":"Br J Clin Pharmacol"},{"key":"997_CR9","doi-asserted-by":"crossref","first-page":"14944","DOI":"10.1016\/S0021-9258(18)33375-1","volume":"257","author":"WE Skiba","year":"1982","unstructured":"Skiba WE, Taylor MP, Wells MS et al (1982) Human hepatic methionine biosynthesis. J Biol Chem 257:14944\u201314948","journal-title":"J Biol Chem"},{"key":"997_CR10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1017\/CBO9780511570216.020","volume-title":"Introduction to the blood\u2013brain barrier, vol. 1","author":"QR Smith","year":"1998","unstructured":"Smith QR, Stoll JS (1998) Blood\u2013brain barrier amino acid transport. In: Pardridge WM (ed) Introduction to the blood\u2013brain barrier, vol. 1. Cambridge, Cambridge University Press, pp 188\u2013197"},{"key":"997_CR11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ymgme.2007.02.012","volume":"91","author":"KA Strauss","year":"2007","unstructured":"Strauss KA, Morton DH, Puffenberger EG et al (2007) Prevention of brain disease from severe 5, 10-methylenetetrahydrofolate reductase deficiency. Mol Genet Metab 91:165\u2013175","journal-title":"Mol Genet Metab"},{"key":"997_CR12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00445602","volume":"142","author":"U Wendel","year":"1984","unstructured":"Wendel U, Bremer HI (1984) Betaine in the treatment of homocystinuria due to 5, 10-methylenetetrahydrofolate reductase deficiency. Eur J Pediatr 142:147\u2013150","journal-title":"Eur J Pediatr"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-009-0997-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-009-0997-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-009-0997-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T05:41:49Z","timestamp":1633412509000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-009-0997-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,12]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["997"],"URL":"https:\/\/doi.org\/10.1007\/s00431-009-0997-x","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,12]]}}}